Trimegah Karya Pratama Tbk PT
IDX:UVCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Trimegah Karya Pratama Tbk PT
IDX:UVCR
|
ID |
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
KY |
|
C
|
Clearfield Inc
SWB:AP7
|
US |
|
M
|
Mercury Trade Links Ltd
BSE:512415
|
IN |
|
Los Andes Copper Ltd
XTSX:LA
|
CA |
|
Iteos Therapeutics Inc
NASDAQ:ITOS
|
US |
|
Inventec Corp
TWSE:2356
|
TW |
|
CCL International Ltd
BSE:531900
|
IN |
|
A
|
AADirection Capital Corp
XTSX:AAD.P
|
CA |
Dividends
Dividend Yield
Trimegah Karya Pratama Tbk PT
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Trimegah Karya Pratama Tbk PT
UVCR have decreased by 0%.
Payout Ratio
Trimegah Karya Pratama Tbk PT
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for UVCR is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
UVCR Price
Trimegah Karya Pratama Tbk PT
| Average Annual Return | -35.29% |
| Standard Deviation of Annual Returns | 37.7% |
| Max Drawdown | -93% |
| Market Capitalization | 282B IDR |
| Shares Outstanding | 2 000 140 000 |
| Percentage of Shares Shorted |
N/A
|
